Kathryn J Swoboda MD FACMG Matthew Sweney MS MD AHCF International Family Conference San Francisco CA June 28 th 2012 What is SUDEP Sudden unexpected witnessed or unwitnessed ID: 275849
Download Presentation The PPT/PDF document "Sudden Unexpected Death in Epilepsy" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Sudden Unexpected Death in Epilepsy
Kathryn J. Swoboda, MD, FACMG
Matthew
Sweney
, MS, MD
AHCF International
Family Conference
San Francisco, CA
June 28
th
, 2012Slide2
What is SUDEP?
Sudden, unexpected, witnessed or
unwitnessed
, non-traumatic, and non-drowning death of a subject affected by epilepsy, with or without evidence for a seizure
Autopsy does not reveal a structural or toxicological cause of death.Slide3
Why talk about SUDEP
The International AHC community has unfortunately witnessed several deaths of AHC children and adults over the past decade
Some of these deaths were entirely unexpected, not preceded or accompanying unusually severe events, and sometimes
occuring
during sleep
I
ndividuals with neurologic and neurodevelopmental disorders have an increased risk for injury or death or illness due to their disabilities,
ie
aspiration or accidental trauma
Understanding when, where and why death or injury occurs in some children and/or adults is critical for our community in order to minimize this problem and to understand itSlide4
Historical Perspective
“Sudden death in a fit” has been noted in medical literature since the mid-19
th
century
Posed as potential cause of death for
Gustave
Flaubert, Prince John of Great Britain, and ancestors of Julius Caesar
Mid 20
th
century
“As far as longevity is concerned, the patient should definitely understand that epilepsy per se rarely causes death and that there is no reason why an epileptic should not live as long as he would if he did not have epilepsy”—Dr. Samuel Livingstone, 1963Slide5
Epidemiology
Mortality (Death) in Epilepsy
Often categorized by epilepsy type and age category
Standardized Mortality Ratio (SMR) for epilepsy = ratio of observed deaths to expected deaths, ranges 1.0 - 7.0 in epileptic patients
Lancet
Neurol
2006; 5: 481–
87
Challenges of Bias
Epilepsy & Behavior 10 (2007) 363–376
x
cases of death in epilepsy/y total cases of death from other
causes
Inaccurate numerator (e.g. inaccurate x
Mis
- or
missed
diagnosis of epilepsy)
Inaccurate denominator (
e.g
inaccurate y
total causes of death in general)
Y is derived from
c
ensus data, which has its own host of problems
Taking confusion one step further…Slide6
Epidemiology
SUDEP pitfalls
Epilepsy
& Behavior 10 (2007) 363–376
Lack of autopsy means cause of death is uncertain
Death
certificate
reliability is often questionable
Cultural and religious sensitivity in reporting death
The role of the specialist center
Excess of severe and rare cases
Longevity selects out early deaths
“lost to follow up” and database linkage
Study design (prospective
vs
retrospective, cohort, case-control, cross-sectional)Slide7
Epidemiology
Lancet
Neurol
2008 (
7
):1021-1031 Slide8
SUDEP in children
Considerably less attention paid
Probably less frequent, some estimate cases range 1-2/10,000 patient years (roughly 1/10 of adult SUDEP)
Rarity makes organized studies challenging
Emphasis on identifying underlying heart problems, promoting medication compliance (see following slides)
Children with seizures and neurologic handicap have higher mortality rate in general, but influence on SUDEP rate is not clear
Camfield
and
Camfield
.
Sem
in Pedi
Neuro
2005 (12):10-14 Slide9
Risk Factors (typically from an adult standpoint)
Epilepsy & Behavior 2009(14):280-287
Epilepsia
2011.
DOI: 10.1111/j.1528-1167.2010.02952.
xSlide10Slide11
Pathophysiologic Mechanisms (Grasping at straws)
Winter weather?
Hibernators have unique protective cardiovascular characteristics—what can we learn from them?.
Med
Hypotheses
2008;70
(5):929-32.
Lunar phase?
SUDEP most common during full moon (70%)
vs
waxing (20%) and new moon (10%)
Epilepsy
Behav
. 2009 Feb;14(2):404-6
409 probable SUDEP showing some evidence supporting link between temperatures and season in SUDEP
Epilepsia
2010 May;51(5):773-6
Geomagnetic forces?
In rats with limbic epilepsy, 10% died following exposure to sham EM field, 60% of died after exposure to natural EM fields
Int
J
Biometeorol
2005 Mar;49(4):256-61
Time of day, date, international geomagnetic indices showed no correlation to SUDEP.
Neurology 2000 Feb 22;54(4):903-8Slide12
Pathophysiologic Mechanisms
Lancet 2008(7):1021-1032Slide13
Cardiac/Autonomic Factors
Autonomic
“storm” or influences on heart during an
epilpetic
seizure
Brain (i.e. seizure) related influences on heart rate
R hemisphere helps contribute to fast heart rate
Tachycardia
is nearly universal pre,
ictal
, or post
Associated with mesial temporal lobe epilepsy
May predispose to
ictal
atrial fibrillation (heart rhythm abnormality occurs during an actual seizure event)
L hemisphere helps contribute to slow heart rate
Bradycardia
(reduced heart rate) during seizure <5% of
pts
Asystole
(heart stops) during seizure <1% of
pts
May be
underestimated, as most of the time, spontaneous recovery occurs
Pathophysiologic Mechanisms
Seizure 2010 (19):455-460
Epilepsia
2010 (5):725-737 Slide14
Cardiac Factors
Long-standing (chronic epilepsy) influences on heart rhythm
Inter-beat interval (
QTc
)
prolongation/shortening
Seizure drugs may affect QT variability (GBP, LTG
may prolong?)
Erratic inter-beat interval (i.e. large QT dispersion) places one at risk for reentry
arryhthmias
(irregular heart beats)
Heart Rate
Variability (how nimble is your heart rate??)
HRV
lower in chronic epilepsy
patients
, resulting in loss of vagal tone and possible
increased likelihood of irregular heart rhythms
Some specific
AEDs
may influence HRV (CBZ,PHT associated with low heart rate during seizure)
Vagal Nerve Stimulator
and
HRV—role is unclear
Pathophysiologic Mechanisms
Seizure 2010 (19):455-460
Epilepsia
2010 (5):725-737 Slide15
Respiratory Factors
The brain (i.e. seizure) influence on respiratory rate
Saturations <90% in 20-30% of all
seizures
Hypoxemia seen with carbon dioxide retention in some
sz
May be protective to some degree—stimulates respiratory drive
Brain-induced fluid in the lungs (Neurogenic Pulmonary Edema)
M
assive adrenaline surge results in
fluid accumulation in lungs
Witnessed SUDEP typically occurs minutes rather than hours following seizure (based on unfortunate cases in epilepsy monitoring units
Brain-induced airway tightening (i.e. Laryngospasm)
Pathophysiologic Mechanisms
Nature Reviews Neurology 2009
(5)
:492-504 Slide16
Cerebral Factors
Cerebral Electrical Shutdown—Brain
flatline
Reported exclusively in cases of LTM SUDEP (when EEG monitoring records the death)
Precedes heart rate slowing and respiratory depression
May be
more common following grand
mal/generalized tonic-
clonic
seizures
Prone
position (face down) may increase risk—
akin to positioning
influence in
sudden
infant death
syndrome
(SIDS)
Pathophysiologic Mechanisms
Epilepsia
2009
(5)
:916-920
Epilepsia
2010 (11):2344-2347 Slide17
Genetic Factors
Increased incidence of SUDEP in
Dravet
Syndrome, an epilepsy syndrome caused by a sodium channel mutation
2% of
Dravet
pts
died from SUDEP based on IDEA League report (cohort of 833 individuals)
Epilepsia
2010 (5):1915-1918
Identification of SCN5A mutation in SUDEP case
Seizure 2009 (2):158-160
Expressed in both the brain and heart—the only case in which a mutated channel is expressed in both locations
Long QT type 2 (VGKC mutation = voltage gated potassium channel) has higher association with epilepsy phenotypes than LQT 1 and 3
Pathophysiologic MechanismsSlide18
Animal Model Studies
Adenosine Mouse Model
Adenosine is endogenous anticonvulsant produced by the body under extreme duress
Impaired adenosine clearance can potentially lead to decreased
ventilatory
rate and apnea (cessation of breathing)
Excess adenosine production combined with decreased clearance has lead to death in mouse models
Adenosine receptor antagonist (caffeine) can extend survival time
.
Could be synergistic to drugs we use to control seizures
No
studies of this in humans
Pathophysiologic Mechanisms
Epilepsia
2010 (3):465-468 Slide19
Animal Model Studies
DBA/2 Mice and
audiogenic
(sound-induced) seizures
88% with respiratory arrest following
audiogenic
seizure (remaining 12% can be induced with
cyproheptadine
—a serotonin blocker)
Mice treated with SSRIs (pro-serotonin drugs) resulted in decreased rates of respiratory arrest and increased rates of survival
Highlights the potential interaction between seizures and respiratory/arousal centers, which are dependent on serotonin
No studies in humans regarding this
Dr.
Chugani’s
work has demonstrated some involvement of the serotonergic system in AHC
Pathophysiologic Mechanisms
Epilepsia
2006 (1):21-26 Slide20
Hypotheses
Hypothesis for post-
ictal
death
Post-
ictal
state may be due in part to stunning of serotonin-related systems
Depression of serotonin-generating neurons could lead to
ictal
and/or postictal
hypoventilation (decreased respiratory rate/effort)
Genetic susceptibilities with bad luck (e.g. prone position) may prevent compensatory response (respiratory drive or arousal)
Seizure/depression/SUDEP phenotype?
—
may be associated with
activity of serotonin
ergic systems in brain and/or brainstem
Some have hypothesized whether
SSRIs may prove protective—unfortunately no answers
Pathophysiologic Mechanisms
Epilepsia
2011 (Suppl. 1):28-38 Slide21Slide22
What about SUDEP and AHC?
Support for diagnosis of
e
pilepsy
in ~50% of AHC patients
Many children/adults have infrequent
seizures
which are
easily
controlled with standard epilepsy medications,
but
status
epilepticus
also occurs
Unclear what role
specific mutations relevant in AHC may
play
in
risk for
SUDEP
, cardiac arrhythmias, or neurotransmitter regulation
Catastrophic
deaths
in AHC
have other causes too
details of such cases may prove helpful
in understanding potential risk factors
,
but broad generalization of individual observations is VERY challengingSlide23
Management Issues
Medication Compliance—
suggests
the importance of adhering
to prescribed treatments for epilepsy, and early treatment intervention for generalized seizures
Need for Bed
Monitors/Supervised sleeping/“Back to sleep”
—
unclear; however, sleep study to rule out sleep-disordered breathing may be indicated in some cases
Anticonvulsant medication
selection and potential interaction with genetic factors
Pacemakers
indicated in rare cases
identified
with
ictal
bradycardia
or
asystole
associated with episodes (slowing or stopped
heartrate
)
VNS protective or
harmful
?
—trade off between improved seizure control and disruption of vagal tone
SSRIs? Caffeine?
—unproven
Provision of oxygen with prolonged seizure activity or spells in which oxygen levels drop below 90% for prolonged periods
Consider asking your doctor about need to monitor oxygen levels if your child has color changes around lips or obvious changes in breathing patterns with any type of spells, or in association with trials of new medicationsSlide24
Future directions
Work with medical advisory board members and other specialist consultant to create specific guidelines for AHC patients
Diagnostic workup including laboratory and genetic evaluations
Standard of care guidelines
Definitions for types of episodes
How to grade episodes and recommendations for interventions including monitoring safety for feeding and breathing during episodes
How to prepare for seizures, and understand risks of associated seizure disorders/status and age of your child Slide25
Acknowledgements
Patients and Families with AHC
Matthew
Sweney
, MS, MD; Aga
Lewelt
MD; Sandy Reyna MD; Abby Smart RN; Tara Newcomb, MS, LCGC
The national and international AHC foundations, who are the primary
liasons
to families and the key to our future success in effectively diagnosing, managing, and treating the many symptoms of AHC